Case Report
Published on 08 Nov 2024
Triple monoclonal protein-related kidney lesions in a patient with plasma cell dyscrasia: a case report
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2024.1399977
- 590 views
- Frontiers in Nephrology
- Onconephrology
- Articles
Type at least 3 characters
17 articles
Articles
Mini Review
Published on 12 Sep 2024
Unraveling monoclonal gammopathy of renal significance: a mini review on kidney complications and clinical insights
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2024.1439288
- 2,414 views
Case Report
Published on 13 Aug 2024
Case report: Successful treatment of renal-limited thrombotic microangiopathy secondary to chronic lymphocytic leukemia
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2024.1400027
- 885 views
Review
Published on 09 Aug 2024
Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2024.1436896
- 4,421 views
- 1 citation
Case Report
Published on 10 Jun 2024
Case report: A case of pseudo-acute kidney injury due to cyclin-dependent kinase inhibitor
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2024.1389562
- 1,523 views
Review
Published on 19 Apr 2024
CAR T-cell therapy and the onco-nephrologist
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2024.1378250
- 1,937 views
- 1 citation
Case Report
Published on 11 Apr 2024
Chemotherapy-induced tubulopathy: a case report series
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2024.1384208
- 1,611 views
Original Research
Published on 04 Apr 2024
Bioinformatics-driven identification of prognostic biomarkers in kidney renal clear cell carcinoma
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2024.1349859
- 1,620 views
- 1 citation
Original Research
Published on 12 Sep 2023
Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2023.1193494
- 1,900 views
- 2 citations
Editorial
Published on 01 Aug 2023
Editorial: Women in onconephrology: 2022
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2023.1240195
- 946 views
Case Report
Published on 20 Jul 2023
Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2023.1168614
- 2,739 views
- 1 citation
Original Research
Published on 27 Feb 2023
The need for kidney biopsy in the management of side effects of target and immunotherapy
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2023.1043874
- 2,578 views
- 4 citations
Correction
Published on 05 Jan 2023
Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2022.1129134
- 614 views
Original Research
Published on 31 Oct 2022
Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2022.1041819
- 3,526 views
- 5 citations
Review
Published on 19 Oct 2022
Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2022.1017921
- 5,302 views
- 13 citations
Case Report
Published on 24 Mar 2022
Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2022.847847
- 2,035 views
- 1 citation